Skip to main contentAll experts

Jeb Justice

CLIN ASO PROF

MD-OTOLARYNGOLOGY-HEAD & NECK

Orcid identifier0000-0003-4729-028X (opens in a new tab)⁠
  • CLIN ASO PROF
    MD-OTOLARYNGOLOGY-HEAD & NECK

GRANTS

  • GRANT
    Vitamin D as a modulator of inflammation in CRS-related olfactory loss
    National Institute of Health Nidcd18 Apr 2025 - 30 Apr 2030
    Active
  • GRANT
    A randomised, double-blind, parallel group Phase III study to assess the efficacy and safety of 100 mg SC depemokimab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) – ANCHOR-1 (depemokimAb iN CHrOnic Rhinosinusitis)
    Glaxosmithkline13 Sep 2022 - 15 Dec 2024
    Expired
  • GRANT
    A Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study of Benralizumab in Patients with Eosinophilic Chronic Rhinosinusitis with Nasal Polyps (ORCHID)
    Astrazeneca Pharm26 Jul 2022 - 11 Jul 2024
    Closed
  • GRANT
    ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA)
    Regeneron Pharmaceuticals6 Jun 2022 - 5 Jun 2027
    Active
  • GRANT
    Role of Vitamin D Metabolism in CRS
    National Institute of Health Niaid22 Mar 2021 - 31 May 2025
    Expired
  • GRANT
    Epithelial cell complement production in the pathogenesis of chronic rhinosinusitis
    National Institute of Health Niaid19 Mar 2021 - 31 Jan 2027
    Active
  • GRANT
    Rapid olfactory tools for telemedicine-friendly COVID-19 screening and surveillance
    National Institute of Health Nidcd21 Dec 2020 - 30 Sep 2023
    Expired